Small Intestinal Bacterial Overgrowth and Systemic Laboratory Parameters: A Multivariable Cross-Sectional Analysis
Open Access
Abstract
Background: Small intestinal bacterial overgrowth (SIBO) has been linked to systemic inflammation and vitamin D deficiency, but its independent clinical relevance remains uncertain. Methods: In this cross-sectional study, 162 adults undergoing hydrogen breath testing were evaluated. Serum 25-hydroxyvitamin D [25(OH)D], leukocyte count, red blood cell distribution width—standard deviation (RDW-SD), and C-reactive protein were analyzed. Associations were assessed using unadjusted comparisons and multivariable regression models adjusted for age, sex, and BMI. Hydrogen increment was additionally examined as a continuous variable. Results: In unadjusted analyses, SIBO-positive individuals had lower 25(OH)D levels and higher leukocyte counts. However, after adjustment for age, sex, and BMI, SIBO status was not independently associated with 25(OH)D, leukocyte count, or RDW-SD. BMI was independently associated with leukocyte count, and age with RDW-SD. Hydrogen increment was not correlated with laboratory parameters. Conclusions: SIBO was not independently associated with vitamin D status or systemic hematological markers. Host-related factors, particularly BMI and age, appeared to have a greater influence on laboratory variability than SIBO.Keywords
This publication has 21 references indexed in Scilit:
- Biology of Anemia: A Public Health PerspectiveThe Journal of Nutrition, 2023
- Small intestinal bacterial overgrowth as a cause of protracted wound healing and vitamin D deficiency in a spinal cord injured patient with a sacral pressure sore: a case reportBMC Gastroenterology, 2020
- ACG Clinical Guideline: Small Intestinal Bacterial OvergrowthAmerican Journal of Gastroenterology, 2020
- Small Intestinal Bacterial OvergrowthGastroenterology Clinics of North America, 2018
- Systematic review with meta‐analysis: rifaximin is effective and safe for the treatment of small intestine bacterial overgrowthAlimentary Pharmacology & Therapeutics, 2017
- Pregnane-X-receptor mediates the anti-inflammatory activities of rifaximin on detoxification pathways in intestinal epithelial cellsBiochemical Pharmacology, 2010
- Rifaximin Is a Gut-Specific Human Pregnane X Receptor ActivatorThe Journal of Pharmacology and Experimental Therapeutics, 2007
- TLR signaling pathwaysSeminars in Immunology, 2004
- Red Cell Distribution Width in the Diagnosis of Iron Deficiency AnemiaIndian Journal of Pediatrics, 2001
- Megaloblastic anaemia due to vitamin B12 deficiency caused by small intestinal bacterial overgrowth: possible role of vitamin B12 analoguesBritish Journal of Haematology, 1986